{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:25:26Z","timestamp":1779913526377,"version":"3.53.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.pbb.2003.09.011","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T03:52:42Z","timestamp":1068090762000},"page":"551-562","source":"Crossref","is-referenced-by-count":11,"title":["Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice"],"prefix":"10.1016","volume":"76","author":[{"given":"Alex V","family":"Yarkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Reploge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2003.09.011_BIB1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(85)90345-0","article-title":"Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats","volume":"113","author":"Arnt","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(87)90144-0","article-title":"Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats","volume":"133","author":"Arnt","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0031-9384(86)90190-3","article-title":"Dose-related response of male rats to apomorphine: snout contact in the open-field","volume":"37","author":"Beck","year":"1986","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2003.09.011_BIB4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"B\u00e9zard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2003.09.011_BIB5","first-page":"794","article-title":"Motor response to a dopamine D3 receptor preferring agonist compared to apomorphine in levodopa-primed 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine monkeys","volume":"283","author":"Blanchet","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2003.09.011_BIB6","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2003.09.011_BIB7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1460-9568.2000.00089.x","article-title":"Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats","volume":"12","author":"Bordet","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0028-3908(99)00064-7","article-title":"Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2\/D3 receptor agonists","volume":"38","author":"Boulay","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2003.09.011_BIB9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0028-3908(98)00213-5","article-title":"Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice","volume":"38","author":"Boulay","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2003.09.011_BIB10","article-title":"Actions of the novel naphtoxazine and dopamine D3\/D2 receptor agonist, S32504, in models predictive of antiparkinsonian properties","volume":"27","author":"Brocco","year":"2001","journal-title":"Abstr.-Soc. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.npp.1380268","article-title":"Lack of discrimination by agonists for D2 and D3 dopamine receptors","volume":"12","author":"Burris","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2003.09.011_BIB12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0014-2999(73)90108-8","article-title":"The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour","volume":"24","author":"Costall","year":"1973","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0028-3908(93)90177-5","article-title":"Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH- DPAT in relation to other \u201cD-2-like\u201d agonists","volume":"32","author":"Daly","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2003.09.011_BIB14","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/0014-2999(93)90533-N","article-title":"Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand","volume":"249","author":"Damsma","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB15","article-title":"Actions of the novel naphtoxazine and dopamine D3\/D2 receptor agonist, S32504, in models predictive of antidepressant properties","volume":"27","author":"Dekeyne","year":"2001","journal-title":"Abstr. - Soc. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002130051133","article-title":"Combined use of mutant mice and classical pharmacology to characterise receptor functions: the case of dopamine D2 and D3 receptors","volume":"147","author":"Depoortere","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2003.09.011_BIB17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246662","article-title":"Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine","volume":"124","author":"Depoortere","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2003.09.011_BIB18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-4159.1999.0720148.x","article-title":"Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum","volume":"72","author":"Dickinson","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2003.09.011_BIB19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0278-5846(95)00110-H","article-title":"Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors","volume":"19","author":"Gagnon","year":"1995","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2003.09.011_BIB20","first-page":"7","article-title":"Characterization of unconditioned behavioral effects of dopamine D3\/D2 receptor agonists","volume":"283","author":"Geter-Douglass","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2003.09.011_BIB21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0091-3057(95)00113-B","article-title":"7-OH-DPAT injected into the accumbens reduces locomotion and sucrose ingestion: D3 autoreceptor-mediated effects?","volume":"52","author":"Gilbert","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2003.09.011_BIB22","first-page":"899","article-title":"Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist (+)-S 14297: II. Both D2 and \u201csilent\u201d D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways","volume":"275","author":"Gobert","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2003.09.011_BIB23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0006-8993(90)90440-M","article-title":"Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity: II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis)","volume":"514","author":"Graham","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2003.09.011_BIB24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2003.01600.x","article-title":"Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice","volume":"84","author":"Gross","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2003.09.011_BIB25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2003.09.011_BIB26","first-page":"1598","article-title":"Behavioral effects of selective dopamine D3 receptor agonist\/antagonist in primate model of Parkinson's disease","volume":"25","author":"Hadjtahar","year":"1999","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB27","series-title":"Comparative cytoarchitectonic atlas of the C57\/BL6 and 129\/Sv mouse brains","author":"Hof","year":"2000"},{"key":"10.1016\/j.pbb.2003.09.011_BIB28","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1073\/pnas.051632598","article-title":"Most central nervous system D2 dopamine receptors are coupled to their effectors by Go","volume":"98","author":"Jiang","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.pbb.2003.09.011_BIB29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0149-7634(83)90017-9","article-title":"Multiple dopamine receptors and behavior","volume":"7","author":"Joyce","year":"1983","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2003.09.011_BIB30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-4886(91)90016-6","article-title":"Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine: I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system","volume":"113","author":"Joyce","year":"1991","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/syn.1035","article-title":"D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period","volume":"40","author":"Joyce","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2003.09.011_BIB32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(01)00139-5","article-title":"Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs","volume":"90","author":"Joyce","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2003.09.011_BIB33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0006-8993(86)91345-4","article-title":"Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D-2 receptor density","volume":"382","author":"Joyce","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2003.09.011_BIB34","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/00001756-200007140-00022","article-title":"The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system","volume":"11","author":"Joyce","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.pbb.2003.09.011_BIB35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0006-8993(02)03396-6","article-title":"Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors","volume":"955","author":"Joyce","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2003.09.011_BIB36","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-4886(03)00353-4","article-title":"Neuroprotective effects of the novel D3\/D2 receptor agonist and antiparkinson agent S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+)and in vivo against 1-methyl- 4-phenyl-1,2,2,6-tetrahydropyridine (MPTP):a comparison to ropinirole","author":"Joyce","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0306-4522(98)00705-2","article-title":"Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors","volume":"91","author":"Jung","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2003.09.011_BIB38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02246265","article-title":"Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning","volume":"122","author":"Khroyan","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2003.09.011_BIB39","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1523\/JNEUROSCI.18-06-02231.1998","article-title":"Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice","volume":"18","author":"Koeltzow","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0306-4522(91)90342-L","article-title":"Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis","volume":"41","author":"LaHoste","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2003.09.011_BIB41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mp.4000754","article-title":"Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments","volume":"5","author":"Lammers","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2003.09.011_BIB42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(86)90541-X","article-title":"Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system","volume":"369","author":"Lau","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2003.09.011_BIB43","first-page":"231","article-title":"The D3 dopamine receptor: neurobiology and potential clinical relevance","volume":"49","author":"Levant","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2003.09.011_BIB44","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1073\/pnas.92.5.1719","article-title":"A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons","volume":"92","author":"L\u00e9vesque","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2003.09.011_BIB45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0006-8993(98)00146-2","article-title":"Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice","volume":"792","author":"L'hirondel","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2003.09.011_BIB46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(99)00704-9","article-title":"Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats","volume":"385","author":"Lorenc-Koci","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB47","first-page":"1467","article-title":"S32504, a novel and potent naphtoxazine agonist at dopamine D3 receptors","volume":"25","author":"Millan","year":"1999","journal-title":"Abstr.-Soc. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB48","first-page":"1063","article-title":"S33084, a novel, potent, selective, and competitive antagonist at dopamine D3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626","volume":"293","author":"Millan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2003.09.011_BIB49","first-page":"1048","article-title":"S33084, a novel, potent, selective, and competitive antagonist at dopamine D3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626","volume":"293","author":"Millan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2003.09.011_BIB50","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1046\/j.1460-9568.1998.00264.x","article-title":"Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies","volume":"10","author":"Morissette","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ana.410370306","article-title":"Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism","volume":"37","author":"Murray","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-3806(91)90038-K","article-title":"Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development","volume":"60","author":"Neal","year":"1991","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.pbb.2003.09.011_BIB53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1098-2302(199805)32:4<313::AID-DEV6>3.0.CO;2-Q","article-title":"Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development","volume":"32","author":"Neal-Beliveau","year":"1998","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0306-4522(00)00130-5","article-title":"Expression of D3 receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment","volume":"98","author":"Quik","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2003.09.011_BIB55","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.870130506","article-title":"Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease","volume":"13","author":"Ryoo","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2003.09.011_BIB56","doi-asserted-by":"crossref","first-page":"30308","DOI":"10.1074\/jbc.M102297200","article-title":"D2\/D3 dopamine receptor heterodimers exhibit unique functional properties","volume":"276","author":"Scarselli","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pbb.2003.09.011_BIB57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00382-3","article-title":"Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL\/6 mice as reflected in climbing activity","volume":"353","author":"Spooren","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01283032","article-title":"Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release","volume":"95","author":"Svensson","year":"1994","journal-title":"J. Neural Transm., Gen. Sect."},{"key":"10.1016\/j.pbb.2003.09.011_BIB59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(82)90084-X","article-title":"Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains","volume":"80","author":"Szechtman","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0028-3908(97)00033-6","article-title":"Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors","volume":"36","author":"Thorn","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2003.09.011_BIB61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(93)90377-T","article-title":"Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats","volume":"243","author":"Van den Buuse","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2003.09.011_BIB62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01277593","article-title":"Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour","volume":"98","author":"Waters","year":"1994","journal-title":"J. Neural. Transm., Gen. Sect."},{"key":"10.1016\/j.pbb.2003.09.011_BIB63","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.18-21-08692.1998","article-title":"Selective activation of G\u00e1o by D2L dopamine receptors in NS20Y neuroblastoma cells","volume":"18","author":"Watts","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2003.09.011_BIB64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-003-1415-0","article-title":"Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors","volume":"167","author":"Wong","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2003.09.011_BIB65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/(SICI)1098-2396(19990301)31:3<210::AID-SYN6>3.0.CO;2-0","article-title":"Dopamine D3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists","volume":"31","author":"Xu","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2003.09.011_BIB66","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1471-4159.2002.00893.x","article-title":"D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens","volume":"81","author":"Zapata","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2003.09.011_BIB67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0028-3908(01)00069-7","article-title":"Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses","volume":"41","author":"Zapata","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2003.09.011_BIB68","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/sj.bjp.0702905","article-title":"Efficient functional coupling of the human D3 dopamine receptor to Go subtype of G proteins in SH-SY5Y cells","volume":"128","author":"Zaworski","year":"1999","journal-title":"Br. J. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305703002867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305703002867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T15:48:19Z","timestamp":1585237699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305703002867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":68,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0091305703002867"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2003.09.011","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}